Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn how the body absorbs and processes 1
dose of cidofovir that is given directly into the bladder, in patients with a viral infection
that is causing bleeding from the bladder.
The safety of this drug dose and the investigational way it is given (directly into the
bladder) will also be studied.